London Investigation Into diElectric Scanning of Lesions

Launched by ROYAL MARSDEN NHS FOUNDATION TRUST · Oct 4, 2017

Keywords

ClinConnect Summary

The early diagnosis of breast cancer is of paramount importance, with a 5-year survival rate of 97% if the cancer is caught "locally", deteriorating to 79% if it has progressed to the "axillary" lymph nodes, and 23% if it has spread to the rest of the body, known as "metastasised."

Diagnosis is currently achieved through clinical examination, imaging with mammography (MMG) and/or ultrasound (US) and needle biopsy. Mammography is dependent upon adequate breast compression to allow greater contrast differentiation between tissue structures, this is not only uncomfortable, but in younger wome...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Attending a symptomatic breast care clinic OR Patients who have a diagnosed or suspected breast cancer (P5/M5/U5/B5).
• • Female sex
• • 18 years or older.
• • Able to provide informed consent.
• • Not in any identified, vulnerable group.
• Exclusion Criteria:
• • Unable to mount MARIA™ patient bed using provided 2-step
• • Unable to lie in the prone position
• • Patients who have undergone biopsy less than 5 days before the MARIA™ scan
• • Patients with implanted electronics.
• • Patients with breast implants.
• • Patients with nipple piercings (unless they are removed prior to the MARIA™ scan)
• • Breast sizes smaller than 197ml or greater than 1L in volume